Редакционная политика
Тематика журнала
Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of diseases. Cell therapy manuscripts can also include application in diseases when cells have been genetically modified. Current Gene Therapy publishes full-length/mini reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of diseases.
Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.
Разделы и направления
Life Sciences
Рецензирование
Bentham Science Publishers follows the double-blind peer review procedure for submissions of all manuscripts to its journals.
All submitted articles are subjected to an extensive peer review in consultation with members of the journal’s editorial board and independent external referees (usually three reviewers). All manuscripts/chapters are assessed rapidly and the decision based on all the peer reviewers' comments, taken by the journal’s Editor-in-Chief, is then conveyed to the author(s).
Submissions from the Editor-in-Chief/Co-Editor/Editorial Board Members will undergo independent peer review and will be submitted to another Editor for his decision on acceptance. For further details, please visit complete guidelines at: https://benthamscience.com/pages/peer-reviews
Use of Generative AI and AI-assisted Technologies in the Peer Review Process
Since the use of AI technology has increased, it has brought its own challenges regarding the originality of the review of submitted manuscripts. Bentham Science has been striving to improve its policies accordingly. With time, we will continue to update our policies to support our reviewers, authors, and editors.
The quality of the peer review of submitted articles has been our top priority. The reviewers are advised not to use AI technologies or any other related assisting resources to generate review reports that could compromise the integrity and confidentiality of the reports.
The full Reviewer Guidelines are available here: https://www.benthamscience.com/journal/28/guideline-for-reviewers